An Observational Study in an Urban Ugandan Clinic comparing Virological Outcomes of Patients Switched from first-line Antiretroviral Regimens to Second-line Regimens containing Ritonavir-boosted Atazanavir or Ritonavir-boosted Lopinavir

Simple item page
dc.contributor.authorLaker, Eva Agnes Odongpiny
dc.contributor.authorNabaggala, Maria Sarah
dc.contributor.authorKaimal, Arvind
dc.contributor.authorNalwanga, Damalie
dc.contributor.authorAbdu Musubire, Abdu Musubire
dc.contributor.authorKiragga, Agnes
dc.contributor.authorLamorde, Mohammed
dc.contributor.authorParkes- Ratanshi, Rosalind
dc.date.accessioned2023-06-28T15:38:10Z
dc.date.available2023-06-28T15:38:10Z
dc.date.issued2019
dc.description.abstractThe World Health Organisation approved boosted atazanavir as a preferred second line protease inhibitor in 2010. This is as an alternative to the current boosted lopinavir. Atazanavir has a lower genetic barrier than lopinavir. We compared the virological outcomes of patients during the roll out of routine viral load monitoring, who had switched to boosted second- line regimens of either atazanavir or lopinavir.en_US
dc.identifier.citationLaker, E. A. O., Nabaggala, M. S., Kaimal, A., Nalwanga, D., Castelnuovo, B., Musubire, A., ... & Ratanshi, R. P. (2019). An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir. BMC Infectious Diseases, 19(1), 1-7.https://doi.org/10.1186/s12879-019-3907-5en_US
dc.identifier.issn1471-2334
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/9019
dc.language.isoenen_US
dc.publisherBMC Infectious Diseasesen_US
dc.subjectLopinaviren_US
dc.subjectSecond-line antiretroviralen_US
dc.subjectAtazanaviren_US
dc.subjectFirst-line failureen_US
dc.titleAn Observational Study in an Urban Ugandan Clinic comparing Virological Outcomes of Patients Switched from first-line Antiretroviral Regimens to Second-line Regimens containing Ritonavir-boosted Atazanavir or Ritonavir-boosted Lopinaviren_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir.pdf
Size:
1.06 MB
Format:
Adobe Portable Document Format
Description:
An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences